Serum Magnesium Status and Its Association With Glycemic Control in Adults With Type 2 Diabetes: A Cross-Sectional
Barani Sri1, Sridurga Mattyvanan1, Rohit S2
1Biochemistry, Vinayaka Mission's Medical College and Hospital, Vinayaka Mission's Research Foundation (Deemed to be University), Karaikal, IND.
Abstract:
Magnesium is a crucial component for insulin production and glucose metabolism, and diminished serum magnesium levels are commonly noted in type 2 diabetes mellitus (T2DM). Despite this relevance, magnesium assessment is not frequently conducted in Indian clinical settings. This study sought to measure serum magnesium concentrations in persons with T2DM and examine their correlation with conventional glycemic indicators. Methods A cross-sectional analytical study was performed with 55 patients with T2DM at a tertiary care hospital. Demographic information, fasting blood sugar (FBS), postprandial blood sugar (PPBS), glycated hemoglobin (HbA1c), and serum magnesium concentrations were documented. Magnesium was quantified by spectrophotometry. Group differences were analyzed using Mann-Whitney and Kruskal-Wallis tests, correlations were evaluated with Pearson's coefficients, and linear regression was employed for predictive analysis. Hypomagnesemia was characterized by serum magnesium levels below 1.70 mg/dL. Results The mean serum magnesium level was 1.95 ± 0.33 mg/dL, and 12 patients (21.8%) had hypomagnesemia. Magnesium did not differ by gender (p = 0.214) or age group (p = 0.287). Magnesium levels varied significantly across HbA1c categories (p = 0.0064). Serum magnesium showed significant inverse correlations with HbA1c (r = -0.41), FBS (r = -0.28), and PPBS (r = -0.34). Patients with hypomagnesemia had higher HbA1c (9.72 ± 2.85%) than those with normal magnesium (7.65 ± 1.94%; p = 0.011). Regression analysis showed no predictive ability. Conclusion Hypomagnesemia is common in T2DM and is strongly associated with poorer glycemic control. Routine magnesium assessment may help identify individuals at higher metabolic risk.
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes III: Clinical Manifestations
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
